Therapy of primary CNS lymphoma with methotrexate-based chemotherapy and deferred radiotherapy: Preliminary results

Neurology

Volumn 46, Issue 6, 1996, Pages 1757-1759

  Cher, Lawrence ^a   Glass, Jon ^b,d   Harsh, Griffith R ^c   Hochberg, Fred H ^c  

^a AUSTIN HEALTH   (Australia)

^b NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; DEXAMETHASONE; DOXORUBICIN; FOLINIC ACID; METHOTREXATE; VINCRISTINE;

ADULT; ARTICLE; BRAIN LYMPHOMA; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL ARTICLE; FEMALE; HUMAN; INTRATHECAL DRUG ADMINISTRATION; MALE; MOUTH ULCER; NAUSEA; NEPHROTOXICITY; PRIORITY JOURNAL; THROMBOCYTOPENIA; VOMITING;

EID: 0030011021     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.46.6.1757     Document Type: Article

References (10)

1. Nelson DF, Martz KL, Bonner H, et al. Non-Hodgkin's lymphoma of the brain: can high-dose, large volume radiation therapy improve survival? Report on a prospective trial by the Radiation Therapy Oncology Group (RTOG): RTOG 8315. Int J Radiat Oncol Biol Phys 1992;23:9-17.
2. Glass J, Gruber ML, Cher L, Hochberg FH. Preirradiation methotrexate chemotherapy of primary central nervous system lymphoma: long-term outcome. J Neurosurg 1994;81:188-195.
3. Neuwelt EA, Goldman DL, Dahlborg SA, et al. Primary CNS lymphoma treated with osmotic blood-brain barrier disruption: prolonged survival and preservation of cognitive function. J Clin Oncol 1991;9:1580-1590.
4. DeAngelis LM, Yahalom J, Thaler HT, Kher U. Combined modality therapy for primary CNS lymphoma. J Clin Oncol 1992;10:635-643.
5. Cristea R, Benbadis S, Rogers L, Estes M. Yield of systemic staging in patients presenting with parenchymal brain lymphoma [abstract]. Ann Neurol 1994;36:294.
6. Glass J, Gruber ML, Hochberg FH. Chemotherapy of primary central nervous system lymphoma (PCNSL) with MCHOD (methotrexate [MTX], cyclophosphamide, Adriamycin, vincristine, dexamethasone) prior to radiation therapy (RT) [abstract]. Neurology 1993;43(suppl 2):A209.
7. Macdonald DR, Cascino TL, Schold SC, Cairncross JG. Response criteria for phase II studies of supratentorial malignant glioma. J Clin Oncol 1990;8:1277-1280.
8. Case records of the Massachusetts General Hospital (case 8-1995). N Engl J Med 1995;332:730-737.
9. Evans WE, Hutson PR, Stewart CF, et al. Methotrexate cerebrospinal fluid and serum concentrations after intermediate-dose methotrexate infusion. Clin Pharmacol Ther 1983;33: 301-307.
10. Lachance DH, Brizel DM, Gockerman JP, et al. Cyclophosphamide, doxorubicin, vineristine, and prednisone for primary central nervous system lymphoma: short-duration response, multifocal intracerebral recurrence preceding radiotherapy. Neurology 1994;44:1721-1727.